Entering text into the input field will update the search result below

HDRO: Hydrogen Hits Peak Pessimism But A New Policy Regime Awaits

May 17, 2023 12:32 PM ETDefiance Next Gen H2 ETF (HDRO)HJEN, HYDR, PLUG
Sean Daly profile picture
Sean Daly
655 Followers

Summary

  • Once a high-flying trading meme, the hydrogen sector has hit peak pessimism.
  • With 300 hydrogen projects targeting heavy transport being developed worldwide, the Defiance Next Gen H2 ETF is well-diversified to capture this fifteen year secular trend across the developed world.
  • 7 to 10 DOE-subsidized regional H2 hubs will be announced this September, offering more than $8 billion in subsidies.
  • Anticipating the announcement and new base of public-private partnership support, expect to see this washed out sector industry to rally in the Fall.

Truck with hydrogen tank trailer

Scharfsinn86

The Defiance Next Gen H2 ETF (NYSEARCA:HDRO) was launched two years ago, arguably five weeks after the peak of the Pandemic Mania, when Robinhood traders --idling in the dead of winter and kindling a stack of Covid checks-- bid up all

HDRO_Country Weightings

HDRO_Country Weightings (MarketVector.com)

HDRO market Cap weightings

HDRO market Cap weightings (MarketVector.com)

Pure Play Hydrogen ETFs: year-over-year performance

Pure Play Hydrogen ETFs: year-over-year performance (Seekingalpha.com)

22 Hubs Encouraged / 7 to 10 to be Chosen

22 Hubs Encouraged / 7 to 10 to be Chosen (Author / Clean Air Task Force website)

This article was written by

Sean Daly profile picture
655 Followers
Sean Daly writes on ETFs, biotech and FINTECH solutions in the banking space.  He teaches international finance and financial risk management at Pace University and was a visiting lecturer at Princeton University from 2005 to 2009.  He was educated at Columbia University.  He has also written extensively on real estate and  economic development, exploring issues as diverse as Chinese urbanization, CMI multilateral currency swap arrangements, energy geopolitics, and Asia's sovereign wealth funds.    Global strategy and private equity background. Equity Approach: long/short, event-driven, with a focus on small cap biotech and the emerging markets.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in HDRO over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.